The company was formed from the merger of Ortho Pharmaceutical and McNeil Pharmaceutical in 1993. Both of these pharmaceutical companies are pioneers and leaders in areas such as pain management, acid reflux disease, and infectious diseases.
Neither Ortho-McNeil-Janssen Pharmaceuticals, Inc. nor Johnson & Johnson undertake to update any forward-looking statements as a result of new information or future ...
As of December 26, 1996 Ortho-McNeil Pharmaceutical, LLC was acquired by Janssen Pharmaceuticals, Inc. Ortho-McNeil Pharmaceutical, LLC develops and provides prescription drugs for women’s health, analgesics, anti-infectives, anti-epileptics, and urology in the United States. It offers various ...
In Ortho-McNeil Pharmaceutical, Inc. v. Mylan Laboratories, Inc., No. 07-1223 (Fed. Cir. Mar. 31, 2008), the Federal Circuit held that the district court correctly construed the claim term “and” in U.S. Patent No. 4,513,006 (“the ’006 patent”) owned by Ortho-McNeil Pharmaceutical, Inc. (“Ortho-McNeil”); affirmed its dismissal of ...
Case opinion for US Federal Circuit ORTHO McNEIL PHARMACEUTICAL INC v. MYLAN LABORATORIES INC. Read the Court's full decision on FindLaw.
ORTHO-McNEIL PHARMACEUTICAL, INC. and Johnson & Johnson Pharmaceutical Research And Development, LLC, Plaintiffs, and Daiichi Pharmaceutical Co., Ltd., Plaintiff-Appellee, v. MYLAN LABORATORIES INC. and Mylan Pharmaceuticals Inc., Defendants-Appellants. United States Court of Appeals, Federal ...
FDA Approves Ortho-McNeil Pharmaceutical, Inc.'s LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis - read this article along with other careers information, tips and advice on BioSpace
- related to Ortho-McNeil Pharmaceutical Inc